Haemonetics (HAE) Tops Q1 EPS by 17c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $101.06 -2.04%
EPS Growth %: 0.0%
Financial Fact:
Provision for income taxes: 3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Provision for income taxes: 3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.59, $0.17 better than the analyst estimate of $0.42. Revenue for the quarter came in at $229.3 million versus the consensus estimate of $219.95 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.17.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
- RH (RH) Tops Q2 EPS by $2.31
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
